Please login to the form below

Not currently logged in
Email:
Password:

European Cancer Congress 2013

This page shows the latest European Cancer Congress 2013 news and features for those working in and with pharma, biotech and healthcare.

ECC 2013: Nintedanib data boosts Boehringer’s oncology ambitions

ECC 2013: Nintedanib data boosts Boehringer’s oncology ambitions

Data from the LUME-Lung 1 study was presented at the European Cancer Congress in Amsterdam and showed that in patients who have advanced non-small cell lung cancer (NSCLC) with ... The cancer is the most common of NSCLC – accounting for around 40 per

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics